Spectroscopic Investigations, DFT Calculations, and Molecular Docking Studies of the Anticonvulsant (2<i>E</i>)-2-[3-(1<i>H</i>-Imidazol-1-yl)-1-phenylpropylidene]-<i>N</i>-(4-methylphenyl)hydrazinecarboxamide

<div>(a) HOMO and (b) LUMO plots of (2<i>E</i>)-IPPMP.</div>

Journal of Spectroscopy

fig4

Figure 4

Figure 4: Spectroscopic Investigations, DFT Calculations, and Molecular Docking Studies of the Anticonvulsant (2<i>E</i>)-2-[3-(1<i>H</i>-Imidazol-1-yl)-1-phenylpropylidene]-<i>N</i>-(4-methylphenyl)hydrazinecarboxamide 

Figure 4 | Spectroscopic Investigations, DFT Calculations, and Molecular Docking Studies of the Anticonvulsant (2E)-2-[3-(1H-Imidazol-1-yl)-1-phenylpropylidene]-N-(4-methylphenyl)hydrazinecarboxamide 